▎Real Consultation Scenario
A 39-year-old patient with AMH 0.9 and a history of one failed IVF cycle asked on an online platform: "I've seen promotions from several Kyrgyzstan hospitals, all claiming many successful cases. Some say thousands, others say tens of thousands. Are these numbers reliable? How should I determine which hospital is truly suitable for me?"
1. Direct Answer: Why "How Many Successful Cases" Is Not a Question with a Standard Answer
In the field of assisted reproduction, the term "successful case" is inherently ambiguous. The "number of successful cases" publicly announced by different hospitals usually varies due to the following:
- Different statistical standards: Some hospitals count "clinical pregnancy cases" (gestational sac seen on ultrasound), while others count "live birth cases" (baby born). The former is typically 15%–25% higher than the latter.
- Different statistical periods: Some count by calendar year, while others count cumulatively since establishment. The latter number is naturally larger.
- Different patient populations: Centers that treat a large number of young egg donor recipients will have significantly higher success case numbers than centers primarily treating older patients using their own eggs.
Therefore, comparing "success case numbers" without considering patient age, etiology, and cycle type is clinically meaningless. More scientific indicators are: clinical pregnancy rate stratified by age group and live birth rate, as well as cycle cancellation rate.
Core Recommendation: Directly ask the hospital to provide clinical pregnancy and live birth rates for the past 1–2 years, stratified by age group (<35, 35–37, 38–40, 41–42, ≥43 years old), and specify whether the statistics are based on "transfer cycles" or "initiated cycles."
2. Why Patients Are Obsessed with the "Number of Successful Cases" Indicator
It is understandable that patients want a simple, intuitive number to evaluate a hospital's reliability. However, the problem is:
- Information asymmetry: Most patients are unfamiliar with the statistical systems of assisted reproduction and are easily attracted by marketing rhetoric like "thousands of successful cases."
- Decision anxiety: Facing an unfamiliar overseas medical environment, patients need a "certainty" indicator to reduce psychological risk.
- Data opacity: Some hospitals use vague statements to avoid disclosing real data, leaving patients with no choice but to rely on "case numbers" for judgment.
From an industry perspective, truly capable hospitals are more proactive in disclosing stratified data rather than just emphasizing total numbers.
3. Doctor's Perspective: Core Indicators for Evaluating Hospital Technical Level
When evaluating a hospital, reproductive doctors focus on the following dimensions:
| Evaluation Dimension | Specific Content | Why It Matters |
|---|---|---|
| Live Birth Rate (LBR) | Proportion of live births per transfer cycle | Closest endpoint indicator to "taking baby home" |
| Clinical Pregnancy Rate (CPR) | Proportion of clinical pregnancies per transfer cycle | Reflects embryo implantation ability |
| Cycle Cancellation Rate | Proportion of cycles cancelled due to poor ovarian response, endometrial issues, etc. | Reflects whether the hospital "selects patients" to embellish data |
| Blastocyst Culture Rate | Proportion of cleavage-stage embryos developing into blastocysts | Reflects the stability of laboratory culture conditions |
| PGT Transferable Rate | Proportion of chromosomally normal blastocysts among those tested | Directly related to age, reflects genetic technology level |
These indicators reflect a hospital's true level much better than "total number of successful cases." If a hospital cannot provide age-stratified data, or if the data covers a short period with a small sample size, its reference value is significantly diminished.
4. Differences Between Hospitals: Laboratory Conditions and Team Experience Are Key
Assisted reproduction hospitals in Kyrgyzstan are mainly located in the capital, Bishkek. Although the country is generally considered a destination for assisted reproduction in Central Asia, technical gaps between hospitals objectively exist:
- Laboratory standards: Some hospitals have introduced international standard embryo culture systems (e.g., Time-lapse, low-oxygen incubators), ensuring a stable culture environment; while a few hospitals have slower equipment updates and greater fluctuations in culture conditions.
- Embryologist experience: The embryologist's micromanipulation experience directly impacts ICSI fertilization rates, assisted hatching, and the accuracy of blastocyst biopsies.
- PGT technology: Hospitals with in-house PGT capabilities can confidently handle complex cases such as advanced maternal age, recurrent miscarriage, and chromosomal abnormalities; hospitals that outsource testing face logistical delays and communication costs.
- International patient service system: Including translation, visa assistance, accommodation arrangements, remote consultations, etc. Although not technical indicators, they directly affect the treatment experience and patient compliance.
5. The Most Easily Overlooked Detail: "Water" in Statistical Standards
Even with "clinical pregnancy rate," different calculation methods can yield completely different numbers. The following situations are not uncommon in the industry:
- Counting only "transfer cycles" rather than "initiated cycles": Patients whose cycles are cancelled are not included in the denominator, making the success rate "look good on the surface."
- Excluding specific populations: For example, patients "aged >42" or with "AMH <0.5" are counted separately or excluded from overall data.
- Using "biochemical pregnancy rate" instead of "clinical pregnancy rate": Biochemical pregnancy (only elevated blood hCG) yields higher numbers, but most result in early miscarriage and are not meaningful.
- Poor data timeliness: Using data from 3–5 years ago, or mixing data from multiple years, masks the current true performance.
Identification Method: When consulting, explicitly ask the hospital to provide clinical pregnancy and live birth rates for 2024–2025, stratified by age group, based on initiated cycles. If they cannot provide this, or only give a vague number, be cautious.
6. Case Scenario Analysis: Why "Number of Successful Cases" Cannot Replace Individual Assessment
Case Background: Patient, female, 41 years old, AMH 0.6, previously had one autologous cycle with no eggs retrieved. At a hospital in Bishkek, she underwent one stimulation cycle, retrieved 2 eggs, formed 1 blastocyst, PGT result was chromosomally normal, transferred, successfully conceived, and now has a live birth.
Analysis: If this hospital advertises "thousands of successful cases," this case would be counted. However, for another 43-year-old patient with AMH=0.3, the same hospital and same doctor might have a completely different success rate. Therefore, the hospital's total number of successful cases has no direct correlation with an individual patient's specific success rate.
Insight: Patients need to obtain data from the hospital based on their own age, ovarian reserve, and medical history for similar populations as a reference, rather than focusing on the total number.
7. Summary of Frequently Asked Questions
Q: What is the approximate range of IVF success rates in Kyrgyzstan?
A: Based on publicly available data from some hospitals and industry exchanges, the clinical pregnancy rate for patients <35 years old is about 55%–70%, 35–37 years old about 45%–60%, 38–40 years old about 30%–45%, 41–42 years old about 15%–25%, and ≥43 years old about 5%–15%. Please note these are reference ranges; specific data should be based on the hospital's official stratified statistics.
Q: What tests should I prepare in advance for IVF in Kyrgyzstan?
A: For women: basic hormone panel (FSH, LH, E2), AMH, antral follicle count, thyroid function, infectious disease screening, and karyotype (optional). For men: semen analysis (including morphology and DNA fragmentation), infectious disease screening, and karyotype (optional). It is recommended to complete these 1–2 months in advance; some tests are valid for 6–12 months.
Q: What should advanced maternal age (>40) patients pay attention to when going to Kyrgyzstan for IVF?
A: Focus on evaluating ovarian reserve (AMH, AFC) and the risk of chromosomal abnormalities. If AMH <0.5, multiple egg retrievals or considering egg donation may be necessary. Additionally, PGT-A can screen for chromosomally normal embryos to reduce miscarriage rates, but confirm whether the hospital has in-house PGT capabilities.
Q: How can I judge whether a hospital's data is authentic?
A: Check whether the data is stratified by age group, whether the statistical period is specified, whether it is based on "initiated cycles," and whether it includes cycle cancellation data. Also, ask the hospital for recent embryo culture records (e.g., blastocyst culture rate, PGT transferable rate) as supporting evidence.
Q: What do the costs at Kyrgyzstan hospitals include? Does a high number of successful cases mean good value for money?
A: Costs typically include examination fees, ovulation induction medication, egg retrieval surgery, embryo culture, and transfer fees. A high number of successful cases does not necessarily mean good value for money. It should be evaluated in conjunction with your personal success rate and total cost. It is recommended to use "cost per live birth cycle" as an economic indicator.
8. Practitioner's Observation: Data Transparency Is a Touchstone of Hospital Credibility
Having worked in the overseas assisted reproduction industry for over 10 years, I have been in contact with many hospitals in Kyrgyzstan. An obvious pattern is: the more transparent the data, the more credible the hospital.
- Hospitals willing to proactively provide stratified data are usually confident in their technology and respect patients' right to know.
- Hospitals that only emphasize "many successful cases" but avoid specific statistical standards often have "room for optimization" in their data.
- Large hospitals indeed have more total cases, but small-scale hospitals that have accumulated in-depth experience with specific populations (e.g., advanced age, repeated failure) are also worth considering.
Additionally, patients are advised to pay attention to one detail during consultation: whether the hospital proactively asks about your age, AMH, and medical history, and then provides data references based on similar populations. If the other party is not interested in your specific situation and only repeatedly emphasizes "we have many successful cases," this itself is a warning sign.
9. When Is It Suitable to Choose an Assisted Reproduction Hospital in Kyrgyzstan
- Suitable for: Patients needing PGT but with a limited budget; patients from Central Asia and surrounding areas concerned about long-haul flights to Europe or America; patients seeking a second opinion or additional cycles.
- Not suitable for: Patients with complex uterine abnormalities, recurrent implantation failure of unknown cause, or requiring cutting-edge reproductive technologies (e.g., in vitro oocyte maturation, mitochondrial replacement). These patients should prioritize medical centers with more comprehensive technical reserves.
10. Risk Assessment and Suggestions for Next Steps
Risk Reminder:
- Data opacity risk: Some hospitals cannot provide the latest age-stratified success rate data. Obtain and retain written data before making any payments.
- Legal and policy risk: Assisted reproduction regulations in Kyrgyzstan differ from those in China. Confirm the legality of egg donation, sperm donation, and embryo donation in advance.
- Medical continuity risk: Overseas treatment involves communication time differences and follow-up difficulties. Choose hospitals with dedicated international patient coordinators.